Hippocrates famously advised doctors

it is far more important to know what person the disease has than what disease the person has. Yet 2,500 years later, ''personalised medicine'', based on individual genetic profiling and the achievements of genomic research, claims to be revolutionary. In this book, experts from a wide range of disciplines critically examine this claim. They expand the discussion of personalised medicine beyond its usual scope to include many other highly topical issues, including: human nuclear genome transfer (''three-parent IVF''), stem cell-derived gametes, private umbilical cord blood banking, international trade in human organs, biobanks such as the US Precision Medicine Initiative, direct-to-consumer genetic testing, health and fitness self-monitoring. Although these technologies often prioritise individual choice, the original ideal of genomic research saw the human genome as ''the common heritage of humanity''. The authors question whether personalised medicine actually threatens this conception of the common good.